Blossomhill Therapeutics Inc <BLSM.O>: Guggenheim initiates coverage with buy rating; target price $30
BLSM•Related News
Iron Horse Acquisition II, ELECTRA AI join Mooving to power battery analytics for India swapping network
IRHO•
Brazil's economy grows 0.5% in second quarter
EWZ•
Paycom Software, Inc. <PAYC.N>: UBS Raises Target Price to $285 From $205
PAYC•
Solta Medical rolls out Fraxel FTX skin resurfacing system in Australia
BHC•
CDT Equity names CFO James Bligh as CEO after Andrew Regan resigns
CDT•